The Claim
Flavone intake is associated with reduced phenotypic age acceleration across all age groups, sexes, races, socioeconomic statuses, and cardiometabolic disease statuses in the U.S. adult population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Higher intake of flavones is linked to slower biological aging as measured by phenotypic age acceleration in U.S. adults, regardless of age, sex, race, income level, or presence of cardiometabolic disease.
See the scientific wording
The association between flavone intake and reduced phenotypic age acceleration is consistent across age groups, sex, race, socioeconomic status, and cardiometabolic disease status, suggesting broad relevance in the U.S. adult population.
Flavones like apigenin and luteolin enter the bloodstream and boost levels of a molecule called NAD+, which turns on a protein called SIRT1. SIRT1 then cleans up damaged cellular components, reduces harmful reactive molecules, and shuts down inflammatory signals. This keeps cells functioning properly, slows down signs of biological aging, and lowers the composite measure of aging based on blood biomarkers.
What the research says
1 studyPeople who ate more flavones (found in foods like parsley and celery) tended to have slower biological aging, and this link held true no matter their age, gender, or whether they had conditions like diabetes or high blood pressure.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.